NeoGenomics Reports Record Revenue of $27.2 Million and Record Adjusted EBITDA of $2.9 Million in Fourth Quarter, Driven by Strong Volume Gains
Go back to NeoGenomics Reports Record Revenue of $27.2 Million and Record Adjusted EBITDA of $2.9 Million in Fourth Quarter, Driven by Strong Volume Gains| NEOGENOMICS (NASDAQ: NEO) | Delayed: 19.91 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.91 | 52 Week High | $9.54 | |||
| Open | $19.91 | 52 Week Low | $5.49 | |||
| Day High | $19.91 | P/E | 497.75 | |||
| Day Low | $19.91 | EPS | $0.04 | |||
| Volume | 110 | |||||

